BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25476515)

  • 1. Molecular genetics of glioblastomas: defining subtypes and understanding the biology.
    Renault IZ; Golgher D
    Neuroimaging Clin N Am; 2015 Feb; 25(1):97-103. PubMed ID: 25476515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathology of malignant gliomas.
    Louis DN
    Annu Rev Pathol; 2006; 1():97-117. PubMed ID: 18039109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular advances of brain tumors in radiation oncology.
    Noda SE; El-Jawahri A; Patel D; Lautenschlaeger T; Siedow M; Chakravarti A
    Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Instability of microsatellites in human gliomas.
    Dams E; Van de Kelft EJ; Martin JJ; Verlooy J; Willems PJ
    Cancer Res; 1995 Apr; 55(7):1547-9. PubMed ID: 7882363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant of the CHEK2 gene as a prognostic marker in glioblastoma multiforme.
    Simon M; Ludwig M; Fimmers R; Mahlberg R; Müller-Erkwoh A; Köster G; Schramm J
    Neurosurgery; 2006 Nov; 59(5):1078-85; discussion 1085. PubMed ID: 17016233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
    Eoli M; Menghi F; Bruzzone MG; De Simone T; Valletta L; Pollo B; Bissola L; Silvani A; Bianchessi D; D'Incerti L; Filippini G; Broggi G; Boiardi A; Finocchiaro G
    Clin Cancer Res; 2007 May; 13(9):2606-13. PubMed ID: 17473190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma therapy: going beyond Hercules Columns.
    Mangiola A; Anile C; Pompucci A; Capone G; Rigante L; De Bonis P
    Expert Rev Neurother; 2010 Apr; 10(4):507-14. PubMed ID: 20367204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
    Kunkle B; Yoo C; Roy D
    Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TERT promoter mutations in primary and secondary glioblastomas.
    Nonoguchi N; Ohta T; Oh JE; Kim YH; Kleihues P; Ohgaki H
    Acta Neuropathol; 2013 Dec; 126(6):931-7. PubMed ID: 23955565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
    Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
    Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular pathology of brain tumors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2005; 122(1):191-6. PubMed ID: 16173698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.
    Aghi M; Gaviani P; Henson JW; Batchelor TT; Louis DN; Barker FG
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8600-5. PubMed ID: 16361543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mutations of PTEN in glioblastoma multiforme.
    Wang SI; Puc J; Li J; Bruce JN; Cairns P; Sidransky D; Parsons R
    Cancer Res; 1997 Oct; 57(19):4183-6. PubMed ID: 9331071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma multiforme - an overview.
    Urbańska K; Sokołowska J; Szmidt M; Sysa P
    Contemp Oncol (Pozn); 2014; 18(5):307-12. PubMed ID: 25477751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular landscape of pediatric brain tumors in the next-generation sequencing era.
    Firme MR; Marra MA
    Curr Neurol Neurosci Rep; 2014 Sep; 14(9):474. PubMed ID: 25037717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DNA methylome of glioblastoma multiforme.
    Martinez R; Esteller M
    Neurobiol Dis; 2010 Jul; 39(1):40-6. PubMed ID: 20064612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis.
    Shirahata M; Iwao-Koizumi K; Saito S; Ueno N; Oda M; Hashimoto N; Takahashi JA; Kato K
    Clin Cancer Res; 2007 Dec; 13(24):7341-56. PubMed ID: 18094416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The definition of primary and secondary glioblastoma.
    Ohgaki H; Kleihues P
    Clin Cancer Res; 2013 Feb; 19(4):764-72. PubMed ID: 23209033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging and genetic influence in treating brain neoplasms.
    Hygino da Cruz LC; Kimura M
    Neuroimaging Clin N Am; 2015 Feb; 25(1):121-40. PubMed ID: 25476517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIK3CA mutations in glioblastoma multiforme.
    Hartmann C; Bartels G; Gehlhaar C; Holtkamp N; von Deimling A
    Acta Neuropathol; 2005 Jun; 109(6):639-42. PubMed ID: 15924253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.